Liver transplantation remains the gold standard for end-stage liver disease, but evolving therapies are reshaping the field. Innovations like machine perfusion technology, expanded donor criteria, and immune tolerance research are improving outcomes and reducing waitlist mortality.
 

At Gastroenterology & Hepatology 2025, international experts will share real-world transplant data, discuss challenges in hepatitis B and C elimination, and explore the gut-liver axis as a frontier for future therapies.
 

Hepatologists, surgeons, and researchers — this is your chance to engage deeply. You can register now, submit an abstract, or check out the full program to plan your participation.